Lymphodepletion-free jl-lightning CAR-T targeting CD19/CD22/BCMA achieved 100% CR in 3 Relapsed/Refractory B-NHL patients: A lymphodepletion regimen comparison studyJinxing Lou, Qijun Qian, Shuya Wang et al.|Blood|2025Cited by 0